Agios Pharmaceuticals
Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially transformative small-molecule medicines. Its product candidate, Pyrukynd (mitapivat), is an activator of both wild-type and mutant pyruvate kinase enzymes, developed for the treatment of hemolytic anemias. The other drug candidates in its pipeline include Tebapivat (PK activator), being developed as a potential treatment for MDS-associated anemia and sickle cell disease, AG-181 (PAH stabilizer), AG-236, and others.www.agios.com
1
MENTIONS
1
EPISODES
1
PODCASTS
Search complete. 1 mention across 1 episode found for "Agios Pharmaceuticals".
Sep 16, 2026
Brian GoffGUEST
Very rewarding to get to know that community and to learn what rare diseases are all about.
Brian GoffGUEST
Four years ago, Agios Pharmaceuticals was making a pivot to really focus almost exclusively on rare blood disorders.
Brian GoffGUEST
And for me, it felt like it was kind of custom made for what i love to do it felt like a calling and and one thing i just wanted to share to your question shamanica about the sickle cell disease community my first it wasn't even my first day it was before i even started in the company but my first meeting with everyone we had two special guests who joined us who are well known in the sickle cell disease warrior community, Demetrius and Blaze.
Brian GoffGUEST
And they both had created this custom song about sickle cell and agios and our mission.